---
schema_version: "secwatch.filing_event.v1"
accession: "0001566469-23-000031"
form_type: "8-K"
ticker: null
cik: "0001566469"
company_name: "NantHealth, Inc."
filed_at: "2023-05-23T23:59:59+00:00"
generated_at: "2026-06-14T17:18:37.096232+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NantHealth to be delisted from Nasdaq on May 24, 2023; plans OTCQB listing

## Summary
- Withdrew hearing request; Nasdaq will suspend trading May 24 due to failure to meet $15M public float requirement.
- Company applied for OTCQB Venture Market quotation; expects continued reporting company status.
- Shares may temporarily trade on OTC Pink until OTCQB transfer finalized.
- Previously disclosed non-compliance on May 2, 2023; compliance period ended May 1.

## SEC filing metadata
- accession: 0001566469-23-000031
- form_type: 8-K
- cik: 0001566469
- company_name: NantHealth, Inc.
- filed_at: 2023-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000031/0001566469-23-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000031/nh-20230519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001566469-23-000031
- JSON: https://secwatch.observer/filing/0001566469-23-000031.json
- Plain text: https://secwatch.observer/filing/0001566469-23-000031.txt

## Key facts
- Listing & Compliance Notices
  NantHealth, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(C)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  - Rules: 5450(b)(2)(C)
  source text: May 22, 2023, the Company received notice from Nasdaq that its shares will be suspended at the open of business on May 24, 2023. Nasdaq is expected to file a Form 25 Notification of Delisting with the Securities Exchange Commission when all internal procedural periods have run. The Company expects and plans for its shares of common stock to be quoted by the OTC Markets Group, Inc. (“OTC”) upon being delisted from Nasdaq and has submitted an application to have its securities traded on the OTCQB Venture Market (“OTCQB”) of OTC. While the Company intends to have its common stock quoted on the OT
  evidence_url: https://www.sec.gov/Archives/edgar/data/1566469/000156646923000031/0001566469-23-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.